Biochemical, structural, and functional characterization of the Nocardia asteroides dihydrofolate reductase: a primary target of anti-nocardiosis treatment
Abstract
Nocardiosis is a human infectious disease caused by several species of Nocardia and primarily affecting the skin, lungs and central nervous system. The first-line treatment is based on cotrimoxazole, combining trimethoprim and sulfamethoxazole. These two drugs respectively target the dihydrofolate reductase (DHFR) and the dihydropteroate synthase (DHPS) involved in the essential folate synthesis pathway. The occurrence of drug resistance to these two drugs is however frequent. While the molecular mechanisms of trimethoprim resistance are well documented in other bacteria, they remain poorly explored and documented in Nocardia. This is partly because few biochemical, structural or genetic studies have been conducted on DHFR from this genus. In this study, we report the biochemical and structural characterization of DHFR from Nocardia asteroides (DHFR Nad ). We show that overexpression of DHFR Nad in N. asteroides confers strong resistance to trimethoprim. We recombinantly expressed and purified active DHFR Nad and determined its inhibition constant for trimethoprim. We solved the crystal structure of DHFR Nad bound to trimethoprim at high-resolution. Further, biochemical studies of mutant DHFR variants pinpointed the role of important residues for trimethoprim binding and drug-resistance.
Related
- Valorization of orange peel by-products via ultrasound-pretreated enzymatic extraction of soluble dietary fiber: Structural and functional characterization
- Comparative Analysis of Starch-Based Films Functionalized with Bixa orellana Fruit and Leaf Extracts: A Multiscale Structural, Morphological, and Optical Characterization
- Integrated Experimental and Computational Investigation of Fluorinated Benzoylthiourea Derivatives: Structural Characterization, Hirshfeld Surface Analysis, Antioxidant Activity, and MAO–B Inhibitory Potential for Parkinson’s Disease
- Preliminary Structural Characterization of an Anti-Inflammatory Polysaccharide from Lysimachia christinae and Its Preventive Effect on Lipopolysaccharide-Induced Acute Liver Injury in Mice
- Polyoxometalate-Assisted Crystallization: A General Strategy Enabling Structural Characterization of Molecular Radium Complexes
BibTeX
@article{couston2026biochemical,
title = {{Biochemical, structural, and functional characterization of the Nocardia asteroides dihydrofolate reductase: a primary target of anti-nocardiosis treatment}},
author = {Julie Couston and Sébastien Lainé and Jérôme Feuillard and Mickaël Blaise},
journal = {Biochimie},
year = {2026},
month = oct,
doi = {10.1016/j.biochi.2026.10.002},
url = {https://hal.science/hal-05800677v1},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Biochemical, structural, and functional characterization of the Nocardia asteroides dihydrofolate reductase: a primary target of anti-nocardiosis treatment
AU - Julie Couston
AU - Sébastien Lainé
AU - Jérôme Feuillard
AU - Mickaël Blaise
PY - 2026
DA - 2026/10/05
JO - Biochimie
DO - 10.1016/j.biochi.2026.10.002
UR - https://hal.science/hal-05800677v1
AB - Nocardiosis is a human infectious disease caused by several species of Nocardia and primarily affecting the skin, lungs and central nervous system. The first-line treatment is based on cotrimoxazole, combining trimethoprim and sulfamethoxazole. These two drugs respectively target the dihydrofolate reductase (DHFR) and the dihydropteroate synthase (DHPS) involved in the essential folate synthesis pathway. The occurrence of drug resistance to these two drugs is however frequent. While the molecular mechanisms of trimethoprim resistance are well documented in other bacteria, they remain poorly explored and documented in Nocardia. This is partly because few biochemical, structural or genetic studies have been conducted on DHFR from this genus. In this study, we report the biochemical and structural characterization of DHFR from Nocardia asteroides (DHFR Nad ). We show that overexpression of DHFR Nad in N. asteroides confers strong resistance to trimethoprim. We recombinantly expressed and purified active DHFR Nad and determined its inhibition constant for trimethoprim. We solved the crystal structure of DHFR Nad bound to trimethoprim at high-resolution. Further, biochemical studies of mutant DHFR variants pinpointed the role of important residues for trimethoprim binding and drug-resistance.
SN - 0300-9084
SN - 1638-6183
ER -